Selected Publications
Christian S, Arain S, Patel P, Khan I, Calip GS, Agrawal V, Sweiss K, Griffin S, Cahill K, Konig H, Esen A, Shergill A, Odenike O, Stock W, Quigley JG. A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia. Am J Hematol 2020 Aug;95(8):937-943. doi: 10.1002/ajh.25838. Epub 2020 May 8. PMID: 32311140; PMCID: PMC9150866.
Last update: May 2025